Podcasts

With the rapid growth of the biopharmaceutical industry, identifying the key trends for cell and gene therapy bioprocessing and manufacture has never been more important. From the sourcing of critical raw materials to streamlining workflows, the demand is not slowing down. Join Tom Fletcher, Scientific Director of Research & Development for FUJIFILM Irvine Scientific as he takes us through the key challenges and drivers that face bioprocessing and where the future could take us.

Explore the Current Challenges and Trends in the Bioprocessing Industry  

Articles

Speed-to-market, flexibility and process efficiency are more important than ever in biopharmaceutical production. And so is the importance of single-use systems. Single Use Support enables innovative process solutions around aseptic fluid management and improves aseptic liquid transfer in various manufacturing facilities. And yet there is hesitation.Dr. Lorenzo De Benedictis provides insights and outlook on the future of single-use systems in Biopharma.

Go With The Flow: How sustainable is the trend toward single-use systems Podcast

When it comes to biotech, both the academic and industry settings are crucial in developing novel medicines. Dr Brent Cezairliyan has experienced both sides of biotech, first through an academic career exploring bacterial pathogenesis, and now in his administrative role at Octagon Therapeutics. The company, headquartered in Cambridge, Massachusetts, focuses on autoimmune disease treatments. By developing targeted approaches to the inflammatory nature of the immune system, they hope their advances in biotech help future scientists navigate the field for years to come. 

Building Biotech Series with Brent Cezairliyan

In this interview we will discuss recent strategies for upstream bioprocess analytics and how a thorough process understanding can improve product quality and process efficiency.


Ep 4: From Data to Control: Process Analytics in Upstream Bioprocess Development

In this podcast, Richard Mirro, business manager at the Bioprocess Center of Eppendorf AG, explores how smart bioprocessing can help labs adapt to today’s demands, driving efficiency while making the development and production of next-generation molecules not only more economical, but also more reliable.

Ep 3: Ready for the Future- Trends in Bioprocessing

In this interview, we will talk about the typical developmental process of new vaccines and how the current Covid-19 situation influences the global vaccine developmental landscape.



Ep 2: Parallel Control and Powerful Software Solutions

After being diagnosed with Hodgkins lymphoma at age 15, Dr Joshua Schiffman was driven to pursue a career in medicine, starting as a pediatric oncologist, and was later drawn to the biotech side of the industry. Dr Schiffman was fascinated with a tidbit of knowledge: elephants almost never get cancer. He met Dr Avi Schroeder at a conference in Israel, and the two wondered how they could take this research about elephants’ cancer-fighting genes and apply it to humans. Together, they co-founded PEEL Therapeutics, the organization’s name meaning elephant in Hebrew, and currently work to bring together nature, medicine, and technology for the betterment of humankind. In this episode, Dr Schiffman provides a hopeful outlook on how nature and biotech can lead scientists to harness the power of evolution and create a bright future for medicine. 

Building Biotech Series with Joshua Schiffman

The Path Forward with Viral Vectors

In this interview, we will talk about the advantages of changing from shake flasks to stirred-tank bioreactors, but also about the problems that can occur and things that have to be considered, in order to ensure proper cell growth.

Ep 1: Bioprocess for Beginners - From Shaker to Bioreactor

While still considering himself a fundamental basic scientist, Samir Ounzain is embracing the biotech industry trend of merging academic research and biotechnological drug development. In this episode, Ounzain talks about his path from a dark theater as a kid watching Jurassic Park to the lab studying the dark matter of the human genome – and eventually to the founding of Haya Therapeutics, a biotech startup aiming to discover and develop safe and effective, tissue- and cell-selective, genome-based therapies for fibrotic diseases.

Sponsored Podcasts